UK Research Ethics Committee’s review of the global first SARS-CoV-2 human infection challenge studies
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia
- Do coronavirus vaccine challenge trials have a distinctive generalisability problem?
- COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement
- Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
- Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
- Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines
- Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model
- Controlled human infection with Neisseria lactamica in late pregnancy to measure horizontal transmission and microbiome changes in mother–neonate pairs: a single-arm interventional pilot study protocol
- Uncertainty, error and informed consent to challenge trials of COVID-19 vaccines: response to Steel et al
- Ethical guidelines for deliberately infecting volunteers with COVID-19